BMD loss occurs early in androgen deprivation therapy

April 11, 2012
BMD loss occurs early in androgen deprivation therapy

(HealthDay) -- The highest average change in bone mineral density (BMD) occurs during early treatment of nonmetastatic, hormone-sensitive prostate cancer in men receiving intermittent androgen deprivation therapy (ADT), according to research published online April 9 in the Journal of Clinical Oncology.

Evan Y. Yu, M.D., of the University of Washington/Fred Hutchinson Cancer Research Center in Seattle, and colleagues conducted a study involving 56 men with nonmetastatic, hormone-sensitive to measure the changes in BMD and associated with each cycle of nine months of treatment with intermittent ADT with leuprolide and flutamide.

The researchers found that, during the first on-treatment period, the decrease in spinal BMD averaged 3.4 percent and the decrease in left hip BMD averaged 1.2 percent; both changes were statistically significant. Spine BMD recovery during the first off-treatment period was significant, with an average increase of 1.4 percent. No significant average changes were observed during subsequent treatment periods. After a median of 5.5 years on trial, one patient (1.8 percent) had a trauma-associated compression fracture.

"To our knowledge, this study is the first to evaluate the dynamics of BMD on intermittent androgen deprivation by looking at DXA scans relative to the treatment cycles of intermittent androgen deprivation. Instead of measuring BMD at baseline and predetermined time points after the initiation of ADT, as was done in the only other report of BMD changes after intermittent androgen deprivation, DXA scans were performed at the beginning of each on- and off-treatment period to more directly assess the impact of testosterone depletion and recovery on BMD changes," the authors write.

Two authors disclosed with Amgen.

Explore further: Fracture prediction methods may be useful for patients with diabetes

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Fracture prediction methods may be useful for patients with diabetes

May 31, 2011
Use of established fracture prediction methods in older patients with type 2 diabetes mellitus (DM) found that scores from these methods were associated with hip and nonspine fracture risk, and a certain score associated ...

Recommended for you

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.